ACI
AMED

AMP Capital Investors’s Amedisys AMED Stock Holding History

AMP Capital Investors’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-2,300
Closed -$563K – 1108
2021
Q2 		$563K Buy
+2,300
New +$603K ﹤0.01% 942
2014
Q1 		– Sell
-14,884
Closed -$217K – 1195
2013
Q4 		$217K Buy
+14,884
New +$240K ﹤0.01% 1151

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

AMP Capital Investors's AMED Position: Q3 2021 in Review

AMP Capital Investors sold out of Amedisys (AMED) in Q3 2021, closing a stake of 2,300 shares — an estimated $563K sold.

AMP Capital Investors first reported a position in AMED in Q4 2013 and held it in 2 quarters. The position peaked at $563K in Q2 2021. 351 funds tracked by Wall St. Rank hold AMED as of Q3 2021.

  • AMP Capital Investors reported no remaining Amedisys position as of Q3 2021 after selling out during the quarter.
  • AMP Capital Investors sold 2,300 Amedisys shares in Q3 2021, an estimated $563K.
  • AMP Capital Investors first reported a position in Amedisys in Q4 2013 and held it in 2 quarters.
  • AMP Capital Investors's Amedisys position peaked at $563K in Q2 2021.
  • 351 funds tracked by Wall St. Rank held Amedisys as of Q3 2021.

Based on AMP Capital Investors's 13F filing for Q3 2021, filed 15 Nov 2021.